Health Catalyst IPO
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. The company's platform helps hospitals and health systems improve clinical outcomes, optimize operations, and reduce costs through advanced data analytics and population health management tools. Investors have been attracted to the company's strong position in the growing healthcare analytics market.
What We Know
Health Catalyst went public in July 2019, trading on the NASDAQ under the ticker symbol HCAT. The company priced its IPO at $26 per share, above the expected range of $22-24, and raised approximately $180 million. The stock performed well initially, reflecting strong investor demand for healthcare technology companies. Since its IPO, Health Catalyst has continued to grow its customer base and expand its platform capabilities. The company has benefited from increased focus on healthcare data analytics and digital transformation, particularly accelerated by the COVID-19 pandemic's impact on the healthcare industry.
Frequently Asked Questions
Has Health Catalyst had an IPO?
Yes, Health Catalyst completed its IPO in July 2019. The company has been publicly traded on the NASDAQ under the ticker symbol HCAT since then.
When is the Health Catalyst IPO date?
Health Catalyst already went public on July 25, 2019. The IPO was priced at $26 per share and raised approximately $180 million for the company.
How can I buy Health Catalyst stock?
You can buy Health Catalyst stock through any brokerage account since it trades publicly on the NASDAQ under the ticker symbol HCAT. The stock is available through traditional brokers, online trading platforms, and investment apps during regular market hours.
Don't Miss the Next Big IPO
Get notified when the next major company files for an IPO. Daily alerts delivered to your inbox.
Get IPO Alerts